The clinical importance of cardioselectivity and lipophilicity in beta blockers.
D000042:Absorption; D000319:Adrenergic beta-Antagonists / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology; D000368:Aged; D000403:Airway Resistance / Q000187:drug effects; D001262:Atenolol / Q000652:urine; D001775:Blood Circulation / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004594:Electrophysiology; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006207:Half-Life; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D050356:Lipid Metabolism; D011485:Protein Binding / Q000187:drug effects; D012083:Renin / Q000097:blood; D014867:Water / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D014867:Water; D001262:Atenolol; D012083:Renin